Russian Medical Inquiry
(RMZh. Meditsinskoe Obozrenie) ISSN 2587-6821 (Print), 2686-9918 (Online)

Therapy of chronic herpesvirus infection in frequently ill children. Possible causes of inefficiency

VAK

Scopus

E-libraryDimensions

russian citation indexULRICHS

roaddoaj

CyberleninkaGoogle Scholar

vinitiResearch4life

MendeleyScilit

РГБWhite list




Open accessCrossrefAntiplagiat

RMJ.ru




DOI: 10.32364/2618-8430-2022-5-4-332-339

A.S. Levina1,2, I.V. Babachenko1,2, N.V. Skripchenko1,2, T.A. Chebotareva3, O.I. Demina3

1St. Petersburg State Pediatric Medical University, St. Petersburg, Russian Federation

2Children’s Scientific Clinical Center of Infectious Diseases of the Federal Medical Biological Agency of Russia, St. Petersburg, Russian Federation

3Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation


Background: therapy for frequently ill children (FIC) with chronic herpesvirus infection includes antivirals and immunomodulators as these patients are considered immunocompromised. According to our data based on the prevalence of diseases and the viral replication activity, therapy may fail in 22% of cases.

Aim: to identify a spectrum of rare genetic variants associated with primary immunodeficiency (PID) detected in FIC with stable, active persistence of herpesvirus infections that were resistant to repeat courses of antiviral and immunotropic therapy.

Patients and Methods: DNA samples of 33 frequently ill children with chronic herpesvirus infection who did not respond to therapy were analyzed using targeted high-throughput multigene sequencing to identify mutations in PID-associated genes.

Results: pathogenic variants matching the potential diagnosis of PID were identified in two (6.1%) children. Rare genetic variants associated with the development of autoinflammatory diseases were found in 54.5% of cases. The p.Gln705Lys NLRP3 gene variant was the most common finding — it was detected in 5 (15.2%) children. Rare variants of the MEFV gene (MEFV p.Thr767Ile and MEFV p.Lys695Arg) were found in three (9.2%) children. In seven (21.2%) children rare variants of the NOD2 gene were identified, in four of them (12.2%) it was NOD2 p.Leu1007fs.

Conclusions: the inefficiency of therapy in frequently ill children with chronic herpesvirus infection could be associated with characteristics of the innate immune system. Such children should be referred to immunology consultant and undergo molecular genetic testing. The detection of rare genetic variants associated with autoinflammatory diseases in more than half of the patients indicates that frequent (occurring every month) diseases with fever may mimic hidden or sometimes typical autoinflammatory diseases, despite the detection of the markers of viral and bacterial agents in a child.

Keywords: frequently ill children, chronic herpesvirus infection, rare genetic variants, primary immunodeficiency.

For citation: Levina A.S., Babachenko I.V., Skripchenko N.V. et al. Therapy of chronic herpesvirus infection in frequently ill children. Possible causes of inefficiency. Russian Journal of Woman and Child Health. 2022;5(4):332–339 (in Russ.). DOI: 10.32364/2618-8430-2022-5-4-332-339.


About the authors:

Anastasia S. Levina — C. Sc. (Med.), associate professor of the Department of Infectious Diseases in Children, St. Petersburg State Pediatric Medical University, 2, Litovskaya str., St. Petersburg, 194100, Russian Federation; infectious disease specialist of the consulting and diagnostic polyclinic, Children’s Scientific Clinical Center of Infectious Diseases of the Federal Medical Biological Agency of Russia; 9, Professor Popov str., St. Petersburg, 197022, Russian Federation; ORCID iD 0000-0003-0470-0672.

Irina V. Babachenko — Dr. Sc. (Med.), Professor of the Department of Infectious Diseases in Children, St. Petersburg State Pediatric Medical University, 2, Litovskaya str., St. Petersburg, 194100, Russian Federation; Head of the Department of Droplet Infections, Children’s Scientific Clinical Center of Infectious Diseases of the Federal Medical Biological Agency of Russia; 9, Professor Popov str., St. Petersburg, 197022, Russian Federation; ORCID iD 0000-0002-1159-0515.

Natalia V. Skripchenko — Dr. Sc. (Med.), Professor, Honored Scientist of the Russian Federation; Head of the Department of Infectious Diseases in Children, St. Petersburg State Pediatric Medical University; 2, Litovskaya str., St. Petersburg, 194100, Russian Federation; Deputy Director for Research, Children’s Scientific Clinical Center of Infectious Diseases of the Federal Medical Biological Agency of Russia; 9, Professor Popov str., St. Petersburg, 197022, Russian Federation; ORCID iD 0000-0001-8927-3176.

Tatyana A. Chebotareva — Dr. Sc. (Med.), Professor, Professor of the Department of Pediatric Infectious Diseases, Russian Medical Academy of Continuous Professional Education; 2/1, Barrikadnaya str., Moscow, 125993, Russian Federation; ORCID iD 0000-0002-6607-3793.

Olga I. Demina — C. Sc. (Med.), assistant of the Department of Pediatric Infectious Diseases, Russian Medical Academy of Continuous Professional Education; 2/1, Barrikadnaya str., Moscow, 125993, Russian Federation; ORCID iD 0000-0002-9511-0995.

Contact information: Anastasia S. Levina, e-mail: rossii@mail.ru.

Financial Disclosure: the research is supported by RSF Grant 15-15-00079. No authors have a financial or property interest in any material or method mentioned.

There is no conflict of interests.

Received 03.10.2022.

Revised 26.10.2022.

Accepted 21.11.2022.


References
1. Schaad U.B., Esposito S., Razi C.H. Diagnosis and management of recurrent respiratory tract infections in children: A practical guide. Archives of Pediatric Infectious Disease. 2016;4(1):e31039. DOI: 10.5812/pedinfect.31039.
2. Wintergerst E.S., Maggini S., Hornig D.H. Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab. 2007;51(4):301–323. DOI: 10.1159/000107673.
3. Shubelko R.V., Zuykova I.N., Shulzhenko A.E. Human herpesviruses infections: clinical features and opportunities of therapy. RMJ. 2018;26(8–1):39–45 (in Russ.).
4. Levina A.S., Babachenko I.V. persistent infection in frequent and prolonged ill children, possibilities of etiopathogenetic therapy. Children infections. 2014;13(4):41–45 (in Russ.). DOI: 10.22627/2072-8107-2014-13-4-41-45.
5. Melehina E.V., Nikolaeva S.V., Soldatova E.Ju. et al. Human herpesvirus 6 variant A/B infections in child population. RMJ. 2019;10:17–21 (in Russ.).
6. Levina A.S., Babachenko I.V., Skripchenko N.V., Imyanitov E.N. The etiological structure of diseases in frequently ill children depending on age. Rossiyskiy Vestnik Perinatologii i Pediatrii. 2017;62(2):72–77 (in Russ.). DOI: 10.21508/1027-4065-2017-62-2-72-77.
7. Babachenko I.V., Levina A.S., Ushakova G.M. et al. Children infections. 2012;11(2):34–37 (in Russ.).
8. Fedyanina O.S., Filippova A.E., Demina O.I. et al. The nature and clinical significance of atypical mononuclear cells in infectious mononucleosis caused by the Epstein-Barr virus in children. J Infect Dis. 2021;223(10):1699–1706. DOI: 10.1093/infdis/jiaa601.
9. Nesterova I.V., Khalturina E.O. Mono- and mixed-herpesvirus infections: association with clinical syndromes of immunodeficiency. RUDN Journal of Medicine. 2018;22(2):226–234 (in Russ.) DOI: 10.22363/2313-0245-2018-22-2-226-234.
10. Yakushyna S.A., Kisteneva L.B., Cheshyk S.G. Principles of the treatment of chronic Epstein–Barr virus infection and associated diseases. Russian Bulletin of Perinatology and Pediatrics. 2019;64(2):38–46 (in Russ.). DOI: 10.21508/1027-4065-2019-64-2-38-46.
11. You Y., Wang L., Li Y. et al. Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients. J Dermatol. 2015;42(6):596–601. DOI: 10.1111/1346-8138.12845.
12. Melekhina E.V., Muzyka A.D., Ponezheva Zh.B., Gorelov A.V. Inosine pranobex experience in children with recurrent respiratory infections. RMJ. 2021;6:27–32 (in Russ.).
13. Melekhina E.V., Muzyka A.D., Lysenkova M.Yu., Gorelov A.V. A comparative analysis of therapeutic regimens in children with monthly respiratory infections and reactivation of infection caused by human herpesvirus type 6. Clinical Practice in Pediatrics. 2018;13(5):74–82 (in Russ.). DOI: 10.20953/1817-7646-2018-5-74-82.
14. Simovanyan E.N., Denisenko V.B., Grigoryan A.V. et al. Epstein-Barr Virus Infection in Children: Improving the Diagnosis and Treatment Program. Children infections. 2016;15(1):15–24 (in Russ.). DOI: 10.22627/2072-8107-2016-15-1-15-24.
15. Mitrofanov A.V., Gasilina E.S., Kitajchik S.M. et al. Comparative efficacy of antiviral therapy for infectious mononucleosis in children. Journal of practical medicine. 2012;7–2(63):63 (in Russ.).
16. Suspitsin E.N., Guseva M.N., Kostik M.M. et al. Next generation sequencing analysis of consecutive Russian patients with clinical suspicion of inborn errors of immunity. Clin Genet. 2020;98(3):231–239. DOI: 10.1111/cge.13789.
17. Theodoropoulou K., Wittkowski H., Busso N. et al.Increased Prevalence of NLRP3 Q703K Variant Among Patients With Autoinflammatory Diseases: An International Multicentric Study. Front Immunol. 2020;11:877. DOI: 10.3389/fimmu.2020.00877.
18. Kazumian M.A., Kozlov I.G., Vasilenok A.V. et al. NOD2 gene polymorphism in children with recurrent respiratory infections. Pediatria n.a. G.N. Speransky. 2022;101(2):38–43 (in Russ.). DOI: 10.24110/0031-403X-2022-101-2-38-43.

License Creative Commons
This work is licensed under a Creative Commons «Attribution» 4.0 License.


Previous article
Next article